Targeting vascular endothelial growth factor with the monoclonal antibody bevacizumab inhibits human hepatocellular carcinoma cells growing in an orthotopic mouse model
Author:
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2008.01762.x/fullpdf
Reference42 articles.
1. 1. Bruix J , Boix L , Sala M , Llovet JP. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 215-9.
2. 2. El-Serag HB , Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-50.
3. 3. Ito Y , Takeda T , Sakon M , et al. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Brit J Cancer 2001; 84: 1377-883.
4. 4. Mise M , Arii S , Higashituji H , et al. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumors. Hepatology 1996; 3: 455-64.
5. 5. Ng IO , Poon RT , Lee JM , Fan ST , Ng M , Tso WK. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol 2001; 116: 838-45.
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications;Cancers;2024-08-19
2. Effect of body mass index on survival in patients with metastatic colorectal cancer receiving chemotherapy plus bevacizumab: a systematic review and meta-analysis;Frontiers in Nutrition;2024-07-16
3. Multidisciplinary treatment for patients with advanced hepatocellular carcinoma complicated by Vp4 portal vein tumor thrombosis: Combination of atezolizumab and bevacizumab after hepatic arterial infusion chemotherapy and radiotherapy: A case series;Medicine: Case Reports and Study Protocols;2024-06
4. Efficacy and safety of atezolizumab plus bevacizumab in patients with portal hypertension for unresectable hepatocellular carcinoma;Cancer Medicine;2024-03
5. Evolution of Systemic Therapy in Advanced Hepatocellular Carcinoma;Surgical Oncology Clinics of North America;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3